
Rethinking law and care for psychosocial disabilities in India
In common parlance, the term borderline often implies ambiguity, something not quite there. But in psychiatric terms, BPD is one of the most severe and complex personality disorders, marked by chronic emotional pain, an abundance of trigger points, a fractured sense of self, a debilitating fear of abandonment, and in some cases, self-injury. The daily struggles of people living with BPD — navigating work, housing, and relationships are largely invisible in domestic, legal, clinical, and social discourse.
While its symptoms vary, the core features include emotional instability, impulsivity, unstable relationships, and chronic feelings of emptiness. People with BPD have a higher suicide rate (5.9%) compared to those with other personality disorders (1.4%), with over 75% having attempted suicide in one study. BPD is also linked to various medical issues like obesity, diabetes, heart disease, chronic pain, and STDs. It often co-occurs with other personality, mood, attention, and eating disorders, as well as PTSD and substance use. Individuals with BPD tend to have shorter life expectancies and face challenges navigating the healthcare system. Yet, BPD remains poorly understood and heavily stigmatised, often weaponised in narratives that label people as toxic, dramatic, or too much.
The Indian mental health discourse rarely makes space for personality disorders. Depression and anxiety dominate conversations, campaigns, and corporate wellness modules, while personality disorders like BPD remain in the shadows. Nowhere is this lack of understanding more visible than in the way Indian law approaches mental illness. Despite two relatively progressive laws — the Mental Healthcare Act, 2017 (MHCA) and the Rights of Persons with Disabilities Act, 2016 (RPWDA), the legal recognition of invisible disabilities like BPD remains patchy.
The MHCA provides the right to community-based care, protection from inhuman treatment, and access to legal aid (Sections 18–28). It also emphasises capacity-based treatment and the autonomy of people with mental illness, a significant shift from paternalistic models. Similarly, the RPWDA includes mental illness under the definition of disability and affirms rights to non-discrimination, education, legal capacity, and community living.
Yet, in practice, these rights remain aspirational. Both Acts lack an implementation framework for chronic, episodic, or invisible disabilities like BPD. While the RPWD Act recognises mental illness within its list of disabilities, it offers no concrete mechanism for invisible and chronic conditions like BPD to gain reasonable accommodations at work, in education, or legal settings. The revised guidelines under the RPWD Act require mental illnesses to persist for at least two years before a permanent disability certificate is issued. However, this delay can hinder early intervention, often crucial in preventing further decline in the individual's mental and social functioning. India's current system relies heavily on medical impairment rather than assessing functional limitations, which can obscure the real-life challenges individuals face. A shift toward functional assessments, in line with global standards, is needed. Notably, an expert committee of the Indian Psychiatric Society recommended a shorter, three-month treatment period before certification, to better reflect persistent disability after adequate care.
First, trauma-informed care should become foundational in both clinical and legal spaces. Personality disorders like BPD are closely linked with early trauma, especially abandonment, sexual abuse, or emotional neglect. Responding with coercion or moral judgment only deepens harm. India urgently requires a substantial expansion of its mental health service infrastructure. This means increasing the number of mental health professionals and facilities, particularly in rural regions, to guarantee that everyone has access to the care they need.
Second, we need legal reform. The RPWD Act must include clearer implementation pathways for those with psychosocial disabilities. Certification and access to benefits, accommodations, or legal support cannot remain a bureaucratic labyrinth. The MHCA must also ensure that its rights-based framework is meaningfully enforceable for people with invisible, non-psychotic conditions.
Third, national mental health programmes must include BPD in awareness campaigns, resource allocation, and therapist training. Dialectical Behaviour Therapy, the leading treatment for BPD, is scarcely available in India and largely unaffordable.
BPD is not a halfway house between sanity and madness; it is a serious, treatable condition demanding reasonable accommodation, empathy, and rights. When we narrow our vision of disability to what's visible—wheelchairs, sign language, or acute psychosis we leave many sufferers stranded in silence. Without an informed and reliable support system, it becomes a cycle of pain, shame, and further isolation. We need systems that understand us, policies that protect us, and a culture that refuses to cast us away as difficult, broken, or dangerous.
This article is authored by Shailee Basu, lawyer and research fellow, Vidhi Centre for Legal Policy, New Delhi.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


India Today
an hour ago
- India Today
Indian-origin US doctor fined $2M for false surgery billing fraud
A 63-year-old Indian-origin pain medicine doctor based in Houston, Texas, has agreed to pay more than $2 million (approximately Rs 17.4 crore) to settle allegations of healthcare fraud, according to the US Ajay Aggarwal agreed to pay $2,053,515 to resolve claims that he submitted false billing to Medicare and to the Department of Labor's Workers' Compensation Programs between November 2021 and March 2023, for surgical procedures that were never actually is an anesthesiologist and pain medicine doctor who also practices in Texas' Bellaire city, Lake Jackson city and Van Vleck (in Matagorda County). He runs his medical practice, called The Pain Relief & Wellness Center, through his own business and a company named PRWCSWTX LLC, according to the statement issued on Monday (August 11) by the US Attorney's Office, Southern District of Texas. Aggarwal billed federally funded healthcare programmes for the surgical implantation of neurostimulator electrodes, according to the statement. These are invasive procedures usually requiring use of an operating room. As a result, Medicare and other federally funded healthcare programmes pay thousands of dollars per procedure, the statement neither Aggarwal nor his staff performed these surgical procedures, according to the allegations, the statement further investigators said Aggarwal instead used electro-acupuncture devices on his patients, which involved inserting thin wires into the ear and taping a small neurostimulator behind the ear – none of which required surgery or treatments were done at Aggarwal's clinic, not a hospital or surgical centre, and no incision was made on a patient, according to the VOWS TO RECOVER LOSSES FROM FRAUDULENT MEDICARE BILLINGUS attorney Nicholas J Ganjei slammed the "fraudulent billing" by the doctor and vowed to recover the losses."A doctor who uses simple medical devices on his patients, yet bills Medicare for a sophisticated spinal surgery, is bilking the American taxpayer, plain and simple," said Ganjei."The Southern District of Texas will ensure that losses to federally funded healthcare programs from fraudulent billing, like what happened here, are recouped and that wrongdoers are held accountable," the attorney month, a doctor of Indian-origin admitted guilt to federal charges related to illegally prescribing strong opioids, resulting in the overdose deaths of two part of his plea, Sanjay Mehta admitted to writing unjustified prescriptions for oxycodone, methadone, and Roxicodone (a branded form of oxycodone hydrochloride) to three different patients in Virginia."Two of the three customers died of opioid intoxication within days of receiving their unlawful prescriptions," US Attorney's Office said in a quantum of Mehta's punishment will be announced on October 31.- Ends


Mint
an hour ago
- Mint
Stakeholder consultation by FSSAI charts roadmap for transparent, responsible food labelling in India
New Delhi [India], August 13 (ANI): The Food Safety and Standards Authority of India (FSSAI) convened a high-level National Stakeholder Consultation on Food Labelling, Advertisement and Claims here in the national capital, bringing together over 700 participants from government, industry, academia, consumer bodies, and regulatory authorities. According to a statement from the Ministry of Health and Family Welfare, the consultation aimed to review existing regulations, address implementation challenges, and align India's standards with global best practices to boost consumer protection, public health, and industry innovation. In her inaugural address, Health Secretary Punya Salila Srivastava stressed the importance of ethical and truthful practices in the rapidly evolving food sector. "We are now exposed to the entire world, which means we must adopt positive changes and scrutinise food products more closely," she noted, adding that such consultations are "vital" in shaping future policy. Nidhi Khare, Secretary, Department of Consumer Affairs, called for an end to misleading advertising and urged manufacturers to treat labelling as a "factor of trust" rather than merely a marketing tool. "Consumers should be left to make the final choice based on truthful and honest declarations," she emphasised, urging collective responsibility to ensure accuracy and transparency in product information. Sanjeev Sanyal, Member, Economic Advisory Council to the Prime Minister, underscored the need for external validation of scientific claims in advertisements. He welcomed FSSAI's decision to implement all label changes annually on July 1, reducing uncertainty for the labelling industry. Additional Secretary, Ministry of Information and Broadcasting, Prabhat, warned against false health and nutrition claims, highlighting their potential to erode public trust and harm health. The event featured technical sessions on global and Indian regulatory frameworks, enforcement case studies, and interactive discussions. Stakeholders exchanged insights on industry accountability, consumer rights, and collaborative enforcement strategies, resulting in actionable recommendations to enhance transparency and trust in food labelling and advertising. This consultation is part of FSSAI's ongoing national dialogue series aimed at building practical, health-aligned policies through close collaboration with industry, academia, and consumer organizations. (ANI)


Time of India
2 hours ago
- Time of India
This rare animal from Bihar is sold for Rs 30000 per kg in China, scientists say its 'medicinal use' is a dangerous myth
The world's most hunted animal, the pangolin, quietly roams the forest of Bihar's Valmiki Tiger Reserve, yet few know of its presence. This scaly, nocturnal creature is the target of relentless poaching, driven by staggering demand in China, where its meat is considered a luxury delicacy and its scales are used in traditional medicine. Let's find out which animal this is. With prices soaring from Rs 27,000 to Rs 30,000 per kilogram, pangolins have become the centrepiece of a brutal black market trade. In China, pangolin meat is considered both a delicacy and a vital component in traditional medicine. Pangolin: Nature's pest controller now a poaching target Wildlife expert Abhishek, with nearly 30 years of experience in animal conservation, highlighted the vital role pangolins play in maintaining ecological balance by keeping termite and ant populations in check. However, their soft meat and keratin scales, made of the same material as human nails, have sadly turned them into high-value targets for poachers. According to News18 Hindi, across much of Asia, particularly in China, , while its scales and bones are widely used in Traditional Chinese Medicine (TCM) to treat everything from arthritis to fertility issues. False medicinal beliefs drive pangolin trafficking Despite these long-held beliefs, scientists across the globe have debunked such claims, stating there is no scientific evidence supporting any medicinal value in pangolin parts. Nonetheless, the demand continues to thrive, driven by cultural tradition and misinformation. This persistent belief has become a key driver of illegal poaching and international smuggling, pushing the already endangered pangolin close to extinction. Where are pangolins found in India? Pangolins, which vary in size from 45 inches to 4.5 feet, exist in eight different species globally. Among them, the Indian pangolin and Chinese pangolin can be found in Bihar's Valmiki Tiger Reserve. In India, these creatures are often referred to as anteaters, thanks to their diet consisting mainly of ants and termites.